Abaxis (ABAX) Tops Q1 EPS by 3c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Abaxis Reports Financial Performance for the First Quarter of Fiscal 2016, Declares Quarterly Cash Dividend
July 23, 2015 4:01 PM EDTUNION CITY, Calif., July 23, 2015 /PRNewswire/ --Â Abaxis, Inc. (NasdaqGS: ABAX), a medical products company manufacturing point-of-care blood analysis systems, today reported financial results for the first fiscal quarter ended June 30, 2015.
First quarter overview:
Revenues from continuing operations of $53.1 million, up 21% over last year's comparable quarter. Diluted EPS from continuing operations of $0.31, up 35% over last year's comparable quarter. Diluted EPS, including discontinued operations, of $0.31, up 48% over last year's comparable quarter.Revenues highlights:
North America revenues from continuing operations of $42.3 million, up 21% over last... More